Group sends doctors tools to foster immunization week

October 01, 2001

'Show & Tell' facts about vaccines during adult immunization week

PHILADELPHIA - This week, American College of Physicians-American Society of Internal Medicine (ACP-ASIM) is launching an educational tool kit to more than 43,000 general internists nationwide to help improve the immunization rates of patients cared for by its members.

The kit was developed as part of the ACP-ASIM Adult Immunization Initiative to help physician members prepare for National Adult Immunization Awareness Week, October 14-20, 2001.

"These free materials are designed to help open the lines of communication between doctor and patient about adult immunization," explains Greg Poland, MD, FACP, chair of the ACP-ASIM Adult Immunization Initiative Physician Advisory Board.

"These patient awareness tools have a central theme of "Show & Tell." They encourage patients to ask their doctors to show them the facts about immunization, and tell their doctors if they have received any immunization at another location, so their records can be updated."

The tools include:

The tools are another offering from the ACP-ASIM Adult Immunization Initiative, a program to help doctors of internal medicine improve the rates of adult immunization against influenza, pneumonia and other vaccine-preventable diseases.

All of these materials are available for download from the Adult Immunization section of the ACP-ASIM Web site at Physician members who were not part of the mailing to general internists will be sent these materials for free upon request.

ACP-ASIM is the nation's largest medical specialty society, with 115,000 internal medicine physicians and medical students. Its three-year immunization initiative includes physician education and office support tools to help incorporate immunization into doctors' practices, and advocacy for adequate reimbursement of vaccines and administration costs.

According to the Centers for Disease Control and Prevention (CDC), an average of 20,000 people, mostly over age 65, die from complications of the flu during epidemics. Every year, more than 10,000 people die from pneumococcal infections.
The ACP-ASIM adult immunization initiative is sponsored by an unrestricted educational grant from Wyeth Lederle Vaccines and Merck Vaccine Division.

American College of Physicians

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to